Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular ...

Among patients who experienced an early cardiovascular event, those treated with semaglutide had approximately 40% fewer ...

Discover how semaglutide reduces heart attack and stroke risk by 20% in overweight individuals, with benefits appearing ...

Semaglutide can rapidly reduce heart attacks and other serious cardiovascular complications in adults with overweight or ...

The weight-loss drug Wegovy slashes the risk of heart disease even before people shed pounds, data suggests. The drug, which contains the active ingredient semaglutide, works by reducing food cravings ...

Within six months, the drug reduced the risk of cardiovascular death by 50% and cut the risk of needing urgent treatment due to heart failure.

The weight-loss drug Wegovy slashes the risk of heart disease even before people shed pounds, data suggests. The drug, which contains the active ingredient semaglutide, works by reducing food ...

Landmark' data has revealed a popular weight loss medicine slashes the risk of heart attack, stroke or heart disease death ...

The drug, which contains the active ingredient semaglutide ... a clinical trial found it reduced the risk of having a heart attack, stroke or heart disease death by 37% in people with obesity ...